Trials / Unknown
UnknownNCT04324034
vNOTES Transvaginal Endoscopic Surgery Versus Laparoscopy
Randomized Study Comparing Endoscopic Transvaginal vNOTES Surgery to Laparoscopy in Terms of Postoperative Pain
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Hospices Civils de Lyon · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The feasibility and safety of laparoscopy are no longer to be demonstrated, especially in the field of gynecology, but this technique often causes post-operative pain. New techniques are being developed to overcome the inconvenience of laparoscopy, notably endoscopic transluminal surgery using a natural orifice (NOTES). It avoids incisions and therefore scarring, and could reduce post-operative pain. It is now developing in the field of transvaginal gynecology (vNOTES). This study is the first prospective randomized study comparing the vNOTES technique to laparoscopy with postoperative pain assessment for performing a salpingectomy. The hypothesis is that the use of vNOTES transvaginal endoscopic surgery would reduce the post-operative pain of patients compared to laparoscopy in the context of a salpingectomy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | vNOTES | vaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES) is vaginal surgery with a natural approach. The GelPOINT V-path transvaginal access platform is used. It is a device designed to be placed transvaginally to establish a pathway for the insertion of minimally invasive instruments while maintaining insufflation to perform diagnostic or operative procedures. This device also allows a passage for the extraction of operating parts. |
| PROCEDURE | laparoscopy | The surgery by conventional laparoscopy is used |
Timeline
- Start date
- 2021-06-03
- Primary completion
- 2026-01-02
- Completion
- 2026-01-02
- First posted
- 2020-03-27
- Last updated
- 2023-02-08
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04324034. Inclusion in this directory is not an endorsement.